Home > Boards > US Listed > Medical - Drugs > Albireo (ALBO)

Albireo now expects to plan the path for

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
cashcow3 Member Profile
 
Followed By 10
Posts 801
Boards Moderated 0
Alias Born 04/09/14
160x600 placeholder
Albireo Recognizes PFIC Awareness Day and Highlights Urgent Needs of Progressive Familial Intrahepatic Cholestasis Families GlobeNewswire Inc. - 10/3/2019 8:00:00 AM
Albireo Announces Presentations at NASPGHAN 2019 Annual Meeting GlobeNewswire Inc. - 9/30/2019 9:23:25 AM
Albireo to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 9/3/2019 8:30:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/8/2019 9:21:17 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/8/2019 8:31:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/8/2019 8:08:44 AM
Albireo Reports Second Quarter 2019 Financial Results GlobeNewswire Inc. - 8/8/2019 7:30:00 AM
Albireo to Present at Wedbush PacGrow Healthcare Conference GlobeNewswire Inc. - 8/6/2019 8:30:00 AM
Albireo to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast GlobeNewswire Inc. - 8/1/2019 8:30:00 AM
Albireo Provides Mid-Year Clinical Development Update GlobeNewswire Inc. - 7/9/2019 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:22:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:01:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 4:57:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 4:54:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 4:50:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 4:49:07 PM
Albireo Announces Launch of “PFIC Voices” GlobeNewswire Inc. - 6/20/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/18/2019 4:02:18 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/7/2019 1:38:51 PM
Data on Albireo’s Odevixibat Presented at 2019 European Society for Paediatric Gastroenterology, Hepatology and Nutrition (... GlobeNewswire Inc. - 6/7/2019 7:00:00 AM
Albireo to Present at Investor Conferences in June GlobeNewswire Inc. - 5/29/2019 7:30:00 AM
Albireo Announces Data on Pediatric Cholestatic Liver Diseases to be Presented at the 2019 ESPGHAN Annual Meeting GlobeNewswire Inc. - 5/23/2019 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 10:10:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 7:48:30 AM
Albireo Reports First Quarter 2019 Financial Results GlobeNewswire Inc. - 5/9/2019 7:30:00 AM
cashcow3   Thursday, 12/22/16 06:24:55 AM
Re: None
Post # of 2110 
Albireo now expects to plan the path for a final "pivotal trial" with the US health authority FDA in the first quarter of 2017, on the basis of which an authorization application for the drug could be submitted

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist